1/81
OMK Block 3 Week 20 PLOs
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
Average total blood volume
5L (7% of body weight); men 75 mL/kg, women 65 mL/kg
Systemic veins & venules
Contain 65–70% of blood volume; major reservoir
Systemic arteries
Contain 10–15% of blood; pressure reservoir
Pulmonary circulation
Contains 10–12% of blood; low-pressure system
Heart chambers
Contain 7–8% of blood volume
Capillaries
Contain 5% of blood; site of exchange
Cardiac output distribution at rest
GI tract/liver 25%, kidneys 20%, skeletal muscle 20%, brain 13–15%, skin 5–10%, coronary 4–5%, other <5%
Arteries structure
Thick walls, smooth muscle, elastic tissue; low compliance
Arteries function
Carry blood under high pressure; maintain flow via elastic recoil
Arterioles structure
Small diameter, thick smooth muscle layer
Arterioles function
Major resistance vessels; regulate flow and TPR
Capillaries structure
Single endothelial layer; no muscle
Capillaries function
Site of gas, nutrient, and waste exchange
Venules & veins structure
Thin walls, large lumens, valves; less smooth muscle
Venules & veins function
Return blood to heart; volume reservoir; high compliance
Pressure
Force per unit area (mmHg)
Pressure gradient
Difference between two points driving flow
Transmural pressure
P(inside) – P(outside); determines vessel diameter and wall tension
Hydrostatic pressure
Pressure from gravity in a fluid column; increases with depth
Mean arterial pressure (MAP)
≈93 mmHg
Aortic pressure
120/80 mmHg
Arteriolar pressure
80→35 mmHg; greatest pressure drop
Capillary pressure
35→15 mmHg
Venous pressure
15→5 mmHg; right atrium 2–5 mmHg
Supine pressure
Hydrostatic effects minimal
Upright pressure
Gravity ↑ venous pressure in legs; ↓ pressure in upper body; valves prevent pooling
Flow (Q)
Volume per unit time (mL/min)
Resistance (R)
Opposition to flow; depends on radius, viscosity, and length
Velocity (v)
Distance per time (cm/s); v = Q/A
Flow equation
MAP = CO × TPR
Laminar flow
Smooth, layered flow; highest velocity at center; Re < 2000
Turbulent flow
Chaotic, mixing flow; Re > 2000; caused by ↑ velocity, ↑ diameter, ↓ viscosity
Active hyperemia
Increased blood flow with ↑ metabolism
Local vasodilators
↓O₂, ↑CO₂, ↑H⁺, ↑K⁺, ↑adenosine, ↑temperature
Reactive hyperemia
Transient ↑ flow after occlusion removal
Endothelium-derived factors
Nitric oxide (dilator), endothelin-1 (constrictor), prostacyclin (dilator)
Cholesterol structure
Steroid nucleus, OH at C3, hydrocarbon tail at C17, double bond in ring B
Cholesterol functions
Membrane fluidity; precursor for bile acids, steroid hormones, vitamin D3
Chylomicrons
High TG, low protein; transport dietary TGs to tissues
Chylomicron remnants
Cholesterol-rich; deliver dietary cholesterol to liver via ApoE
VLDL
High TG, some cholesterol; transport hepatic TGs to tissues
LDL
Cholesterol-rich; deliver cholesterol to tissues (“bad”)
HDL
High protein; reverse cholesterol transport (“good”)
Exogenous lipid pathway
Dietary lipids → chylomicrons (ApoB-48) → LPL hydrolyzes TGs → remnants to liver via ApoE
Endogenous lipid pathway
Liver lipids → VLDL (ApoB-100) → LPL forms IDL → LDL → tissues via LDL receptors; HDL returns cholesterol to liver
Single-nucleotide variants (SNVs)
Single base substitution (e.g. sickle cell)
Insertions/deletions (indels)
Addition or loss of nucleotides (e.g. frameshift)
Copy number variations (CNVs)
Gain or loss of large DNA segments (e.g. DiGeorge)
Microsatellites (STRs)
Short repeating DNA units (e.g. Huntington’s)
Chromosomal rearrangements
Translocations, inversions, duplications, deletions (e.g. Philadelphia chromosome)
Epigenetic modifications
DNA methylation, histone acetylation; alter expression without sequence change
Endogenous mutation sources
DNA replication errors, deamination (C→U), depurination, repair/recombination errors
Exogenous mutation sources
Radiation, chemical mutagens, viruses, oxidative stress
Hardy-Weinberg equilibrium
Frequencies constant if no drift, mutation, migration, selection, or nonrandom mating
Hardy-Weinberg uses
Estimate carrier frequency; predict risk; check genotyping accuracy
Hardy-Weinberg limitations
Assumptions rarely met; real populations deviate
Genome
All DNA (coding + noncoding) in nucleus and mitochondria
Exome
All protein-coding regions (exons); ~85% of disease mutations
Mean
Arithmetic average; affected by outliers
Median
Middle value; resistant to outliers
Mode
Most frequent value; used for categorical data
Variance
Average of squared deviations from mean
Standard deviation (SD)
Square root of variance; spread of data
Standard error (SE)
SD/√n; variability of sample means around population mean
P value
Probability results occurred by chance under null hypothesis
Alpha (α)
Significance threshold, often 0.05
Interpretation of P value
P < α → reject null; P ≥ α → fail to reject null
Type I error
False positive; reject true null; false claim of difference
Type II error
False negative; fail to reject false null; miss real effect
Power
1 – β; low power ↑ Type II error risk
Cholesterol structural feature
Four fused hydrocarbon rings with –OH at C3, hydrocarbon tail at C17
Saturated fatty acid
All single bonds; straight chain; solid at room temp
Monounsaturated fatty acid
One cis double bond; one kink
Polyunsaturated fatty acid
≥2 cis double bonds; flexible; oxidized easily
Omega-6 fatty acid
First double bond at C6 from ω-end; linoleic family
Omega-3 fatty acid
First double bond at C3 from ω-end; α-linolenic, EPA, DHA
Short-chain fatty acid
≤6 carbons; soluble; gut-derived
Medium-chain fatty acid
6–12 carbons; rapidly metabolized
Long-chain fatty acid
≥14 carbons; need carnitine transport
Even-chain fatty acid
2-carbon units from acetyl-CoA; normal human synthesis
Odd-chain fatty acid
Ends in propionyl-CoA; from dairy/bacteria
Essential fatty acids
Linoleic and α-linolenic acids; cannot be synthesized